Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.06M Buy
8,459
+188
+2% +$64.4K 0.13% 115
2026
Q1
$2.91M Buy
8,271
+148
+2% +$52.8K 0.15% 97
2025
Q4
$2.66M Buy
8,123
+527
+7% +$167K 0.13% 117
2025
Q3
$2.14M Sell
7,596
-384
-5% -$111K 0.12% 126
2025
Q2
$2.23M Sell
7,980
-918
-10% -$260K 0.15% 96
2025
Q1
$2.77M Buy
8,898
+2,115
+31% +$625K 0.23% 76
2024
Q4
$1.77M Buy
6,783
+182
+3% +$54K 0.16% 95
2024
Q3
$2.13M Buy
6,601
+366
+6% +$120K 0.19% 87
2024
Q2
$1.95M Buy
6,235
+756
+14% +$222K 0.18% 89
2024
Q1
$1.56M Buy
5,479
+532
+11% +$156K 0.15% 104
2023
Q4
$1.42M Buy
4,947
+1,476
+43% +$402K 0.15% 108
2023
Q3
$933K Buy
+3,471
New +$866K 0.12% 113

Other funds holding AMGN

Syon Capital's AMGN Position: Q2 2026 in Review

Syon Capital increased its Amgen (AMGN) stake by 2.3% in Q2 2026, buying an estimated $64.4K and bringing the position to 8,459 shares worth $3.06M. The position accounts for 0.13% of the portfolio, ranked #115.

Syon Capital first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Syon Capital held 8,459 shares of Amgen worth $3.06M as of Q2 2026.
  • Syon Capital bought 188 Amgen shares in Q2 2026, an estimated $64.4K.
  • Amgen made up 0.13% of Syon Capital's portfolio in Q2 2026, its #115 holding.
  • Syon Capital first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.